Assessment Report

Fri, 12 Jun 2026 03:40:32 +0000

Introduction

This is a slightly redacted/tidied up version of my ADHD assessment report received in May of 2026 after providing written evidence and conducting a 1 hour interview with a clinician.

I have removed the names of the doctor and clinician.

I’m sharing here for reference by others to understand my own symptoms and what they can expect a report to contain.

NOTE Nothing in this report should be taken as medical advice. It was specifically created for my own diagnosis and treatment.

Clinical Management Plan

Prescribing medication and monitoring of response during titration will be undertaken by Harrow Health.
Patients will have their blood pressure, heart rate and weight checked prior to being issued any stimulant medications.
Please inform us if systolic BP is more than 140, diastolic is more than 90, or if resting pulse is more than 100 or is irregular (the patient should self-monitor blood pressure and heart rate).
He will be referred to our medication titration service to start stimulant medication. The risks and side effects of this group of medication include nausea, headaches, a lack of sleep, a lack of appetite and other side effects have been discussed and will be explored further when treatment commences.
He has been given detailed information of the common side effects of medication and any red flag symptoms that would mean medication should be discontinued and that they should seek further medical assistance.
Once stability of the dose is achieved, we will arrange a final follow-up appointment with our Clinician to inform you of the need for ongoing medication and management and ask for your consideration of a shared care agreement.

Medication Plan

In accordance with the NICE Guidelines (NG87) for the management of Adult ADHD, we plan to commence stimulant medication, which is the first-line treatment recommendation.

My ADHD on

Assessment Report

Introduction

Clinical Management Plan

Medication Plan